U.S. FDA approves Catalyst Pharma's rare disease drug

The U.S. Food and Drug Administration approved on Wednesday Catalyst Pharmaceuticals Inc's drug to treat a rare autoimmune disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news